FDA Set to Decide on Two Likely Blockbuster Drugs By Sanofi Genzyme

... d division of Sanofi (NYSE: SNY) that's focused on specialty pharmaceuticals (formerly called simply Genzyme), and Tarrytown, N.Y.-based Regeneron Pharmaceuticals (Nasdaq: REGN).
http://ift.tt/2ddDceO